RU2763728C1 - Application of 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one as antimicrobial agent - Google Patents
Application of 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one as antimicrobial agent Download PDFInfo
- Publication number
- RU2763728C1 RU2763728C1 RU2021118804A RU2021118804A RU2763728C1 RU 2763728 C1 RU2763728 C1 RU 2763728C1 RU 2021118804 A RU2021118804 A RU 2021118804A RU 2021118804 A RU2021118804 A RU 2021118804A RU 2763728 C1 RU2763728 C1 RU 2763728C1
- Authority
- RU
- Russia
- Prior art keywords
- oxoethylidene
- morpholin
- nitrophenyl
- application
- antimicrobial activity
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Изобретение относится к области органической химии, а именно к применению индивидуальных соединений класса 3-(2-арил-2-оксоэтилиден)морфолин-2-онов в качестве средств, обладающих противомикробной активностью, которые могут быть использованы в качестве исходных продуктов для синтеза новых гетероциклических систем и в фармакологии.The invention relates to the field of organic chemistry, namely the use of individual compounds of the class 3-(2-aryl-2-oxoethylidene)morpholin-2-ones as agents with antimicrobial activity, which can be used as starting products for the synthesis of new heterocyclic systems and in pharmacology.
Заявленное соединение 3-(2-(4-нитрофенил)-2-оксоэтилиден)морфолин-2-он и способ синтеза его производных известны из уровня техники. Заявляемое соединение является продуктом взаимодействия ароилпировиноградных кислот с этаноламином или пропан-2оламином («Синтез пирроло[2,1-с][1,4]оксазин-1,6,7-трионов взаимодействием 3-метиленморфолин-2-онов с оксалилхлоридом», Третьяков Н.А., Дмитриев М.В., Масливец А.Н., ЖОрХ, 2020, 56, №8, 1203. [Synthesis of Pyrrolo[2,l-c][l,4]oxazine-l,6,7-triones by the Reaction of 3-Methylenemorpholin-2-ones with Oxalyl Chloride. Tretyakov N.A., Dmitriev M.V., Maslivets A.N. Russ. JOC, 2020, 56(8), 1367-1373. doi: 10.1134/S1070428020080060]), образуется по следующей схеме:The claimed compound 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one and the method for the synthesis of its derivatives are known from the prior art. The claimed compound is a product of the interaction of aroylpyruvic acids with ethanolamine or propan-2olamine (“Synthesis of pyrrolo[2,1-c][1,4]oxazine-1,6,7-triones by the interaction of 3-methylenemorpholin-2-ones with oxalyl chloride”, Tretyakov N.A., Dmitriev M.V., Maslivets A.N., ZHORH, 2020, 56, No. 8, 1203 -triones by the Reaction of 3-Methylenemorpholin-2-ones with Oxalyl Chloride Tretyakov NA, Dmitriev MV, Maslivets AN Russ JOC, 2020, 56(8), 1367-1373 doi: 10.1134/S1070428020080060]), is formed by the following scheme:
где: 1 Ar=Ph (а), 4-СlС6Н4 (б), 4-BrC6H4 (в), 4-MeC6H4 (г), 4-MeOC6H4 (д), 4-NO2C6H4 (e);where: 1 Ar \u003d Ph (a), 4-ClC 6 H 4 (b), 4-BrC 6 H 4 (c), 4-MeC 6 H 4 (d), 4-MeOC 6 H 4 (e), 4-NO 2 C 6 H 4 (e);
2 R=Η (a), Me (б); 3 R=H, Ar=Ph (а), 4-СlС6Н4 (б), 4-BrC6H4 (в), 4-MeC6H4 (г), 4-МеОС6Н4 (д), 4-NO2C6H4 (e), R=Me, Ar=Ph (ж), 4-СlС6Н4 (з), 4-BrC6H4 (и),2 R=H (a), Me (b); 3 R=H, Ar=Ph (a), 4-СlС 6 Н 4 (b), 4-BrC 6 H 4 (c), 4-MeC 6 H 4 (d), 4-MeOC 6 Н 4 (e ), 4-NO 2 C 6 H 4 (e), R=Me, Ar=Ph (g), 4-СlС 6 Н 4 (h), 4-BrC 6 H 4 (i),
4-МеС6H4 (й), 4-МеОС6H4 (к).4-MeC 6 H 4 (d), 4-MeOS 6 H 4 (j).
Противомикробная активность 3-(2-арил-2-оксоэтилиден)морфолин-2-она ранее не была исследована.The antimicrobial activity of 3-(2-aryl-2-oxoethylidene)morpholin-2-one has not been previously investigated.
Задачей изобретения является изыскание новых соединений, обладающих противомикробной активностью, и расширение арсенала средств воздействия на живой организм.The objective of the invention is to find new compounds with antimicrobial activity, and to expand the arsenal of means of influencing a living organism.
Поставленная задача решается тем, что соединение 3-(2-(4-нитрофенил)-2-оксоэтилиден)морфолин-2-он проявляет высокую противомикробную активность в концентрации в 1000 мкг/мл.The problem is solved by the fact that the compound 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one exhibits high antimicrobial activity at a concentration of 1000 μg/ml.
Синтезируют заявляемое соединение путем взаимодействия (4-нитробензоил)пировиноградной кислоты с этаноламином в среде растворителя с последующим выделением целевого продукта, по следующей схеме:The claimed compound is synthesized by reacting (4-nitrobenzoyl)pyruvic acid with ethanolamine in a solvent medium, followed by isolation of the target product, according to the following scheme:
Процесс ведут при температуре 108-110°С с насадкой Дина-Старка для отделения воды, а в качестве растворителя используют толуол.The process is carried out at a temperature of 108-110°C with a Dean-Stark nozzle to separate water, and toluene is used as a solvent.
Изобретение иллюстрируется следующими примерами.The invention is illustrated by the following examples.
Пример 1. 3-(2-(4-Нитрофенил)-2-оксоэтилиден)морфолин-2-он (4а).Example 1 3-(2-(4-Nitrophenyl)-2-oxoethylidene)morpholin-2-one (4a).
К раствору 130.1 ммоль (4-нитробензоил)пировиноградной кислоты в 300 мл толуола добавляли уксусной кислоты 130.1 ммоль и 130.1 ммоль моноэтаноламина, кипятили 6 ч с насадкой Дина-Старка (до прекращения выделения воды), растворитель удаляли, перекристаллизовывали в этилацетате, осадок отфильтровывали. Выход 75%, т.пл. 267-269°С (ЕЮАс).To a solution of 130.1 mmol (4-nitrobenzoyl)pyruvic acid in 300 ml of toluene was added 130.1 mmol of acetic acid and 130.1 mmol of monoethanolamine, refluxed for 6 h with a Dean-Stark trap (until the evolution of water ceased), the solvent was removed, recrystallized in ethyl acetate, and the precipitate was filtered off. Yield 75%, m.p. 267-269°C (EyuAc).
Соединение (4а) C12H10N2O5.Compound (4a) C 12 H 10 N 2 O 5 .
Найдено, %: С 55.21; Η 3.69; N 10.54Found, %: С 55.21; H 3.69; N 10.54
Вычислено, %: С 54.97; Η 3.84; N 10.68.Calculated, %: С 54.97; H 3.84; N 10.68.
Соединение (4а) - темно-желтое кристаллическое вещество, легкорастворимое в ДМСО и ДМФА, трудно растворимое в менее полярных органических растворителях, нерастворимое в воде и алканах. Устойчиво при хранении в обычных условиях.Compound (4a) is a dark yellow crystalline substance, readily soluble in DMSO and DMF, sparingly soluble in less polar organic solvents, and insoluble in water and alkanes. Stable under normal storage conditions.
В ИК спектре соединения (4а), записанном в виде пасты в вазелиновом масле, присутствуют полосы валентных колебаний NH в виде широкого пика при 3202 см-1, узкого пика нитро группы NO2 3074 см-1, кетонной карбонильной группы при 1730 см-1 и ароильной карбонильной группы при 1623 см-1.In the IR spectrum of compound (4a), recorded as a paste in vaseline oil, there are bands of NH stretching vibrations in the form of a broad peak at 3202 cm -1 , a narrow peak of the nitro group NO 2 3074 cm -1 , ketone carbonyl group at 1730 cm -1 and an aroyl carbonyl group at 1623 cm -1 .
В спектре ЯМР 1Н соединения (4а), записанном в растворе в ДМСО-d6, кроме сигналов протонов ароматических колец, присутствует группа из 4 метиленовых протонов этоксильного заместителя при 3.65 м.д. (дд, 2Н, С4H2, J 8.3, 5.4 Гц), 4.60 м.д. (дд, 2Н, С3H2, J 5.8, 4.7 Гц), соответственно, синглет метанового протона енаминового фрагмента при 6.56 м.д. (1Н, СН=), и синглет протона группы NH при 10.53 м.д.The 1 H NMR spectrum of the compound (4a) recorded in solution in DMSO-d 6, except the proton signals of the aromatic rings, there is a group of 4 methylene protons of the ethoxy substituent at 3.65 ppm (dd, 2H, C 4 H 2 , J 8.3, 5.4 Hz), 4.60 ppm (dd, 2Н, С 3 H 2 , J 5.8, 4.7 Hz), respectively, the singlet of the methane proton of the enamine fragment at 6.56 ppm. (1H, CH=), and a singlet of the proton of the NH group at 10.53 ppm.
Пример 2. Фармакологическое исследование соединения (4а) на наличие противомикробной активности.Example 2 Pharmacological study of compound (4a) for antimicrobial activity.
Для исследований использовали общепринятый метод двукратных серийных разведений в жидкой питательной среде микрометодом [Руководство по экспериментальному (доклиническому) изучению новых фармакологических веществ - М.: И-во Медицина, 2005]. Готовили исходные разведения микроорганизмов в физиологическом растворе из суточной агаровой культуры по оптическому стандарту мутности (ОСО) на 5 ME с использованием денситометра. После ряда разведений конечная концентрация клеток в опыте составляла 2,5×105 клеток/мл.For research, the generally accepted method of two-fold serial dilutions in a liquid nutrient medium by the micromethod was used [Guidelines for the experimental (preclinical) study of new pharmacological substances - M.: I-vo Medicine, 2005]. Initial dilutions of microorganisms in physiological saline were prepared from daily agar culture according to the optical turbidity standard (OCO) for 5 ME using a densitometer. After a series of dilutions, the final concentration of cells in the experiment was 2.5×10 5 cells/ml.
Противомикробные свойства химического вещества изучали на 3-х коллекционных условно-патогенных штаммах микроорганизмов: Staphylococcus aureus (штамм 906), Escherichia coli (штамм 1257), Candida albicans, 1353.The antimicrobial properties of the chemical were studied on 3 collection opportunistic strains of microorganisms: Staphylococcus aureus (strain 906), Escherichia coli (strain 1257), Candida albicans, 1353.
Соединение (4a) подавляет рост S. aureus в концентрации 500,0 мкг/мл, гибель культуры наступает от концентрации в 1000 мкг/мл.Compound (4a) inhibits the growth of S. aureus at a concentration of 500.0 μg/ml, culture death occurs from a concentration of 1000 μg/ml.
Предлагаемое вещество 3-(2-(4-нитрофенил)-2-оксоэтилиден)морфолин-2-он (4а) обладает фармакологической активностью, а именно противомикробной активностью, и может найти применение в фармакологии в качестве потенциального лекарственного средства.The proposed substance 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one (4a) has pharmacological activity, namely antimicrobial activity, and can be used in pharmacology as a potential drug.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2021118804A RU2763728C1 (en) | 2021-06-17 | 2021-06-17 | Application of 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one as antimicrobial agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2021118804A RU2763728C1 (en) | 2021-06-17 | 2021-06-17 | Application of 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one as antimicrobial agent |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2763728C1 true RU2763728C1 (en) | 2021-12-30 |
Family
ID=80040035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2021118804A RU2763728C1 (en) | 2021-06-17 | 2021-06-17 | Application of 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one as antimicrobial agent |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2763728C1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2781380C1 (en) * | 2022-02-18 | 2022-10-11 | Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" | 5-hydroxy-4-{ [(4-methoxyphenyl)(4-nitrophenyl)amino]methylidene} -5-(trifluoromethyl)dihydrofuran-2,3-dione, exhibiting antimicrobial activity |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1167881A1 (en) * | 1984-04-12 | 1996-03-27 | Пермский государственный университет им.А.М.Горького | Fenylhydrazide of morpholinediethylacetic acid |
WO1999037305A1 (en) * | 1998-01-21 | 1999-07-29 | Glaxo Group Limited | Pharmaceutically active morpholinol |
-
2021
- 2021-06-17 RU RU2021118804A patent/RU2763728C1/en active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU1167881A1 (en) * | 1984-04-12 | 1996-03-27 | Пермский государственный университет им.А.М.Горького | Fenylhydrazide of morpholinediethylacetic acid |
WO1999037305A1 (en) * | 1998-01-21 | 1999-07-29 | Glaxo Group Limited | Pharmaceutically active morpholinol |
Non-Patent Citations (1)
Title |
---|
формула. Tret’yakov, N. A. и др.: " Synthesis of Pyrrolo[2,1-c][1,4]oxazine-1,6,7-triones by the Reaction of 3-Methylenemorpholin-2-ones with Oxalyl Chloride", Russian Journal of Organic Chemistry, 56(8), с.1367-1373, oi:10.1134/S1070428020080060 соединение 3f. * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2781380C1 (en) * | 2022-02-18 | 2022-10-11 | Федеральное государственное автономное образовательное учреждение высшего образования "Пермский государственный национальный исследовательский университет" | 5-hydroxy-4-{ [(4-methoxyphenyl)(4-nitrophenyl)amino]methylidene} -5-(trifluoromethyl)dihydrofuran-2,3-dione, exhibiting antimicrobial activity |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2763728C1 (en) | Application of 3-(2-(4-nitrophenyl)-2-oxoethylidene)morpholin-2-one as antimicrobial agent | |
RU2763732C1 (en) | Application (r*)-3-(4-chlorobenzoyl)-2-hydroxy-3а-(r*)-2-oxoindolin-3-yl)-5-phenylpyrrolo [1,2-a]quinoxalin-1,4(3аh,5h)-dione as antimicrobial agent | |
RU2742883C1 (en) | (1's*,2'r*,3r*,7a's*)-2'-nitro-1',2',5',6',7',7a'-hexahydrospiro[pyrrol-3,3'-pyrrolisin]-2(1h)-ones | |
RU2707196C1 (en) | 3-(2-aryl-2,4-dihydroxy-1(2-hydroxyethyl)-5-oxo-2,5-dihydro-1h-pyrrol-3-yl)quinoxaline-2(1h)-ones having analgesic activity and a method for production thereof | |
RU2763730C1 (en) | Application of 3-(4-chlorobenzoyl)-2-hydroxy-3-(2-oxo-indolin-3-yl)-1h-benzo[b]pyrrolo[1,2-d][1,4]-oxazin-1,4(3аh)-dione as an agent with antimicrobial activity | |
RU2294330C1 (en) | 5-methyl-2-oxo-1-phenyl-4-ethoxycarbonyl-2,3-dihydro-1h-pyrrole-3-spiro-2-(3-benzoyl-4-hydroxy-1-ortho-hydroxyphenyl-5-oxo-2,5-dihydropyrroles) eliciting antimicrobial activity with respect to gram-positive microflora and method for their preparing | |
RU2790479C1 (en) | Application of 9-aroyl-8-hydroxy-6-(2-hydroxyalkyl)-2-imino-1-thia-3,6-diazaspiro[4,4]non-8-en-4,7-diones as agents, with antimicrobial activity | |
RU2783264C1 (en) | 3-(4-CHLOROBENZOYL)-2-HYDROXY-3a-(2-HYDROXY-4,4-DIMETHYL-6-OXOCYCLOHEX-1-en-1-yl)PYRROLO[1,2-a]QUINOXALIN-1,4 (3aH,5H)-DIONE WITH ANTIMICROBIAL ACTIVITY AND METHOD FOR ITS PRODUCTION | |
RU2806037C1 (en) | Application of 3-(2,4-dihydroxy-1-(2-hydroxypropyl)-5-oxo-2-(4-chlorophenyl)-2,5-dihydro-1h-pyrrol-3-yl)quinoxalin-2(1h)-one as an agent with antimicrobial activity against cultures of s. aureus and c. albicans | |
RU2783287C1 (en) | Application of 3-(4-chlorobenzoyl)-2-hydroxy-3a-(2-oxo-5-fluoroindolin-3-yl)-1h-benzo[b]pyrrolo[1,2-d][1,4]-oxazine -1,4(3ah)-dione as an agent with antibacterial and antifungal activity | |
RU2790379C1 (en) | The use of 9-aroyl-8-hydroxy-6-(2-hydroxyalkyl)-2-thioxo-1,3,6-triazaspiro[4.4]non-8-en-4,7-diones as agents with antimicrobial activity against s. aureus | |
RU2791043C1 (en) | Use of 9-benzoyl-8-hydroxy-6-(2-hydroxyethyl)-2-phenyl-1-thia-3,6-diazaspiro[4.4]none-2,8-dien-4,7-dione as an antifungal drug | |
RU2813484C1 (en) | Use of 9-aroyl-8-hydroxy-6-(2-hydroxyalkyl)-1,3-diphenyl-1,3,6-triazaspiro[4,4]non-8-ene-2,4,7-triones agents with antimicrobial activity against s. aureus culture | |
RU2767658C1 (en) | N-(4-methoxyphenyl)-3,4-di(4-methylbenzoyl)-1h-pyrazole-5-carboxamide, having antimicrobial activity, and a method for production thereof | |
RU2806194C1 (en) | USE OF 3-ARYL-6H-SPIRO[BENZO[b]FURO[3',4':2,3]PYRROLO[1,2-d][1,4]OXAZINE-5,3'-INDOLINE]-1, 2,2',6-TETRAONES AS AGENTS WITH ANTIBACTERIAL AND ANTIFUNGAL ACTIVITIES | |
RU2828102C1 (en) | Use of 9-aroyl-8-hydroxy-6-(2-hydroxyalkyl)-1,3,6-triazaspiro[4,4]non-8-ene-2,4,7-triones as agents having antimicrobial activity against culture of staphylococcus aureus and candida albicans | |
RU2806040C1 (en) | Method for producing 4-aroyl-1-(2-hydroxyaryl)-5-(1h-indol-3-yl)-1,3-dihydro-2h-pyrrole-2,3-diones with antimicrobial activity | |
RU2763731C1 (en) | Application of 9-aroyl-8-hydroxy-6-(2-hydroxyalkyl)-1,3-dialkyl-2-thioxo-1,3,6-triazaspiro[4.4 non-8-ene-4,7-diones as agents with antimicrobial activity | |
RU2803888C1 (en) | Application of 8-hydroxy-6-(2-hydroxyethyl)-9-(4-methylbenzoyl)-2-phenyl-1-thia-3,6-diazaspiro[4.4]non-2,8-diene-4,7-dione as an agent with antimicrobial activity against the s. aureus culture | |
RU2770598C1 (en) | Application of antifungal agent based on 2-((4-r1-5-r2-3-(ethoxycarbonyl)thiophene-2-il)amino)-4-oxo-4-r3-but-2-eno acids in relation to candida aldicans | |
RU2806038C1 (en) | Application of 3'-(4-bromobenzoyl)-4'-hydroxy-1'-(2-hydroxyethyl)spiro[benzo[b][1,4]thiazine-2,2'-pyrrole]-3,5'(1 'h,4h)-dione as agent with antimicrobial activity against s. aureus culture | |
RU2806041C1 (en) | Method for producing methyl 3-benzoyl-4-hydroxy-1-(2-hydroxyphenyl)-2-(1h-indol-3-yl)-5-oxo-2,5-dihydro-1h-pyrrole-2-carboxylate having antimicrobial activity | |
RU2763141C1 (en) | Ethyl (3r*, 3a'r*, 8a'r*,8b's*)-1', 2,3'-trioxo-2',5-diphenyl-1-(4-chlorophenyl)-1,2,2',3',3a',6 ',7',8',8a',8b'-decahydro-1'h-spiro[pyrrol-3,4'-pyrrolo[3,4-a]pyrrolisine]-4-carboxylate with anti-microbial activity | |
RU2806039C1 (en) | METHOD FOR PRODUCING 3-AROYL-4-HYDROXY-1-(2-HYDROXYARYL)-1',3'-DIMETHYLSPIRO[PYRROLE-2,5'-PYRROLO[2,3-d]PYRIMIDINE]-2',4', 5,6'(1H,1'H,3'H,7'H)-TETRAONES WITH ANTIMICROBIAL ACTIVITY | |
RU2784521C1 (en) | Application of 8-chloro-1-methyl-4,5-dihydro-6h-pyrrolo[1,2-a][1,4]benzodiazepin-6-one as antibacterial agent against gram-positive microorganisms |